These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23674386)

  • 21. α-Synuclein rs356219 polymorphisms in patients with Gaucher disease and Parkinson disease.
    Altarescu G; Ioscovich D; Alcalay RN; Zimran A; Elstein D
    Neurosci Lett; 2014 Sep; 580():104-7. PubMed ID: 25111979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O; Lopez GJ; Nussbaum RL
    Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
    Toffoli M; Dreussi E; Cecchin E; Valente M; Sanvilli N; Montico M; Gagno S; Garziera M; Polano M; Savarese M; Calandra-Buonaura G; Placidi F; Terzaghi M; Toffoli G; Gigli GL
    Neurol Sci; 2017 Jul; 38(7):1233-1240. PubMed ID: 28409245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA
    Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at onset in LRRK2-associated PD is modified by SNCA variants.
    Botta-Orfila T; Ezquerra M; Pastor P; Fernández-Santiago R; Pont-Sunyer C; Compta Y; Lorenzo-Betancor O; Samaranch L; Martí MJ; Valldeoriola F; Calopa M; Fernández M; Aguilar M; de Fabregas O; Hernández-Vara J; Tolosa E
    J Mol Neurosci; 2012 Sep; 48(1):245-7. PubMed ID: 22669510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.
    Li NN; Mao XY; Chang XL; Zhao DM; Zhang JH; Liao Q; Yu WJ; Tan EK; Peng R
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jul; 162B(5):452-6. PubMed ID: 23737253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Han W; Liu Y; Mi Y; Zhao J; Liu D; Tian Q
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):123-34. PubMed ID: 25656566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
    Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T
    Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.
    Cardo LF; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Pastor P; Samaranch L; Mata IF; Díaz M; Moris G; Menéndez M; Corao AI; Alvarez V
    J Mol Neurosci; 2012 Jul; 47(3):425-30. PubMed ID: 22076805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SNCA 3' UTR Genetic Variants in Patients with Parkinson's Disease.
    Blažeković A; Jerčić KG; Borovečki F
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.
    Fernández-Santiago R; Garrido A; Infante J; González-Aramburu I; Sierra M; Fernández M; Valldeoriola F; Muñoz E; Compta Y; Martí MJ; Ríos J; Tolosa E; Ezquerra M;
    Mov Disord; 2018 Apr; 33(4):637-641. PubMed ID: 29473656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
    Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
    Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
    Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
    Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
    Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
    JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.
    Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T
    FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.
    Mata IF; Shi M; Agarwal P; Chung KA; Edwards KL; Factor SA; Galasko DR; Ginghina C; Griffith A; Higgins DS; Kay DM; Kim H; Leverenz JB; Quinn JF; Roberts JW; Samii A; Snapinn KW; Tsuang DW; Yearout D; Zhang J; Payami H; Zabetian CP
    Arch Neurol; 2010 Nov; 67(11):1350-6. PubMed ID: 21060011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of genome-wide association study-linked loci in Parkinson's disease of Mainland China.
    Liu J; Xiao Q; Wang Y; Xu ZM; Wang Y; Yang Q; Wang G; Tan YY; Ma JF; Zhang J; Huang W; Chen SD
    Mov Disord; 2013 Nov; 28(13):1892-5. PubMed ID: 23853107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.